The company utilizes third-party manufacturing facilities, specifically a contract development and manufacturing organization (CDMO), to produce its products, including CTx-1301. In February 2026, the FDA conducted a pre-approval inspection of the CDMO's facility, resulting in a Form 483 with three observations. Reliance on third-party manufacturers limits the company's control over the manufacturing process and may cause delays, increased costs, and regulatory compliance risks. The company depends on suppliers to provide components and active pharmaceutical ingredients (APIs) in a timely manner and at reasonable prices. Issues such as delays, pricing, or challenges with DEA quotas for scheduled components could affect the commercialization and clinical trials of its products. Additionally, shortages of raw materials from third-party suppliers may impact production.
Cingulate Inc's Comment on Supply Chain
The company utilizes third-party manufacturing facilities, specifically a contract development and manufacturing organization (CDMO), to produce its products, including CTx-1301. In February 2026, the FDA conducted a pre-approval inspection of the CDMO's facility, resulting in a Form 483 with three observations. Reliance on third-party manufacturers limits the company's control over the manufacturing process and may cause delays, increased costs, and regulatory compliance risks. The company depends on suppliers to provide components and active pharmaceutical ingredients (APIs) in a timely manner and at reasonable prices. Issues such as delays, pricing, or challenges with DEA quotas for scheduled components could affect the commercialization and clinical trials of its products. Additionally, shortages of raw materials from third-party suppliers may impact production.
Sources:
Cingulate Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Cingulate Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
